Chih‐Chun Lee

Medicine · Indiana University

Pancreatic function and diabetes Diabetes and associated disorders Ion Channels and Receptors RNA modifications and cancer MicroRNA in disease regulation

Publications

Citations

328

Est. group size

—

Recurring co-author estimate

Active years

Publishing since 2002

Research summary

AI-generated

Chih-Chun Lee works in medicine with a focus on immune system regulation and inflammation, including studies of immune cells (such as regulatory T and B cells) and immune-related side effects of treatments. Related work touches on cancer models, metabolic conditions like diabetes, and innate immunity in animals. The research spans laboratory and disease-oriented topics.

Immune regulation and inflammationImmune-related adverse events of therapyCancer models and immune cellsInnate immunityMetabolic disease (diabetes)

Publication activity has generally grown over the past decade, with a peak of 11 papers in 2023 and an average of about 4.4 per year over the last five years.

Generated by claude-opus-4-8 from public bibliographic data · Jul 11, 2026

Publication cadence

Publications per year over the last 10 years — averaging 4.4/year recently

Recent publications

ISID0488 - Dual blockade of IL-4 and IL-13 with dupilumab reduces severity of type 2 inflammatory immune-related adverse events
2023
Lysosomal Acid Lipase Deficiency Controls T- and B-Regulatory Cell Homeostasis in the Lymph Nodes of Mice with Human Cancer Xenotransplants
American Journal Of Pathology · 2020
AVIAN INNATE IMMUNITY WITH AN EMPHASIS ON CHICKEN MELANOMA DIFFERENTIATION-ASSOCIATED GENE 5 (MDA5)
Taiwan Veterinary Journal · 2019

Publishes in

Diabetes×16
bioRxiv (Cold Spring Harbor Laboratory)×6
PMC×2
EBioMedicine×1
Journal of Biological Chemistry×1

This profile was generated automatically from public scholarly data (OpenAlex). Group size and activity levels are estimates derived from co-authorship patterns.

Last updated Jul 11, 2026.

Claim or correct this profile